Back

Efficacy and safety of Shexiang Baoxin pill in patients with ischemia with non-obstructive coronary arteries (LESS): a phase 4, multicenter, randomized, double-blind, placebo-controlled clinical trial

2 September 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Acute and chronic coronary syndromes Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mrs Na Li

Shanghai Changzheng Hospital, Shanghai (China)

6 More presentations in this session

Presentation thumbnail
Methylome of circulating cell free DNA as a novel biomarker tool: from acute coronary syndrome to broader risk stratification of cardiovascular disease
Doctor A. Kratzer (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
How to predict myocardial injury in patients with large ischaemic burden identified during stress echocardiography?
Doctor K. Vakalis (Harefield, Uxbridge, GB)
Abstract Slides Video
Presentation thumbnail
Longitudinal and cross-sectional associations of NT-proBNP with kidney function and chronic kidney disease: results from KORA cohort studies
Mr J. Lin (Neuherberg, DE)
Abstract Slides Video
Presentation thumbnail
Coronary sinus reducer device for the treatment of refractory angina: a single center experience
Doctor M. Sobral Domingues (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Symptomatic patients without coronary artery disease do not have excess cardiovascular risk compared to the general population
Doctor K. Olesen (Aarhus, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Acute and chronic coronary syndromes

The Event

Event poster

ESC Congress 2024

2 September 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
A randomized, double-blind, placebo-controlled, mechanistic trial on the safety, tolerability and pharmacodynamics of ninerafaxstat in patients with angina and chronic coronary syndrome
thumbnail
Congress Presentation
Qiliqiangxin in patients with heart failure and reduced ejection fraction - the QUEST study
thumbnail
Congress Presentation
Recover with INOCA: A randomized, prospective study of a cardiac rehabilitation program in patients with ischemia with nonobstructive coronary artery disease (INOCA)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources